Evidence map›Paper›PMID 37439340›Full record

ArticleHaematologica2024

Actin-bundling protein L-plastin promotes megakaryocyte rigidity and dampens proplatelet formation.

Li Guo, Shancy Jacob, Bhanu Kanth Manne, E Motunrayo Kolawole, Siqi Guo, Xiang Wang, Darian Murray, Emilia A Tugolukova, Irina Portier, Yasuhiro Kosaka and 6 more

Abstract readLetter
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Li GuoProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT; Bloodworks Research Institute, Seattle, WA; Hematology Division, University of Washington, Seattle, WA.
Shancy JacobProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
Bhanu Kanth ManneProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
E Motunrayo KolawoleDepartment of Pathology, University of Utah, Salt Lake City, UT.
Siqi GuoProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT; Applied Mathematics, Department of Mathematics, University of Utah, Salt Lake City, UT.
Xiang WangHSC Cell Imaging Core, School of Medicine, University of Utah, Salt Lake City, UT.
Darian MurrayProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
Emilia A TugolukovaProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
Irina PortierProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
Yasuhiro KosakaProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
Cindy BarbaDepartment of Pathology, University of Utah, Salt Lake City, UT.
Matthew T RondinaProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT; Department of Pathology, University of Utah, Salt Lake City, UT; Department of Internal medicine, University of Utah, Salt Lake City, UT; George E. Wahlen Department of Veterans Affairs Medical Center, Department of Internal Medicine, and Geriatric Research, Education, and Clinical Center (GRECC), Salt Lake City, UT.
Brian EvavoldDepartment of Pathology, University of Utah, Salt Lake City, UT.
Celeste MorleyPediatrics, Infectious Diseases, Washington University, St. Louis, MO; Pathology and Immunology, Washington University, St. Louis, MO.
Seema BhatlekarProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT. saseems@gmail.com.
Paul F BrayProgram in Molecular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT. Paul.bray@hsc.utah.edu.

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
New Therapies to Restore Vascular Integrity During SepsisR01HL130541 · NHLBI · UNIVERSITY OF UTAH · PI ODELBERG, SHANNON J, WEYRICH, ANDREW S · 2016 to 2020
$3.7M
Defining how TCR strength of signal modulates Treg functionR01AI169835 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Brian D Evavold · 2022 to 2026
$3.1M
In vivo studies of megakaryocyte microRNAs regulating platelet number and integrin activationR01HL141424 · NHLBI · UNIVERSITY OF UTAH · PI BRAY, PAUL F. · 2018 to 2021
$2.5M
Translational Control of Megakaryocyte and Platelet Function in SepsisR01HL142804 · NHLBI · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2018 to 2021
$1.9M
CONTROL OF ADAPTIVE IMMUNITY BY ACTIN-REGULATORY PROTEINSR01AI104732 · NIAID · WASHINGTON UNIVERSITY · PI MORLEY, SHARON CELESTE · 2014 to 2018
$1.9M
Platelet Immune Responses in Aging and InfluenzaR01AG048022 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2014 to 2018
$1.8M
Platelet-Leukocyte Interactions in SepsisK24HL155856 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2021 to 2025
$606k
Novel Regulatory Mechanisms of Inflammation-Induced ThrombosisR56AG059877 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2018 to 2018
$381k
Platelet Reprogramming During InflammationI01CX001696 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI Matthew Thomas Rondina · 2018 to 2026
–
American Heart Association-American Stroke Association 906231American Heart Association-American Stroke Association 938717CSRD VA I01 CX001696NCI NIH HHS P30 CA042014NHLBI NIH HHS K24 HL155856NHLBI NIH HHS R01 HL130541NHLBI NIH HHS R01 HL141424NHLBI NIH HHS R01 HL142804NIAID NIH HHS R01 AI104732NIAID NIH HHS R01 AI169835NIA NIH HHS R01 AG048022NIA NIH HHS R56 AG059877
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ActinsMegakaryocytesHumansMembrane GlycoproteinsMicrofilament ProteinsPhosphoproteinsActinsMembrane GlycoproteinsMicrofilament ProteinsPhosphoproteinsplastin

Identifiers

PMID37439340
PMCPMC10772514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.